Alteration of tight junctions in intestinal transplantation induced by Campath-1H.
Li
Qiurong
Q
Zhang
Qiang
Q
Wang
Chenyang
C
Li
Yuanxin
Y
Li
Yousheng
Y
Li
Ning
N
Li
Jieshou
J
Wu
Bo
B
Liu
Xiaoxiang
X
D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000187:drug effects; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000187:drug effects; D062445:Claudin-1; D062465:Claudin-3; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000637:transplantation* / Q000648:ultrastructure; D018655:Lymphocyte Count; D008565:Membrane Proteins / Q000378:metabolism; D008854:Microscopy, Electron; D019108:Tight Junctions / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D055815:Young Adult
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; C568108:CLDN1 protein, human; C568122:CLDN3 protein, human; D062445:Claudin-1; D062465:Claudin-3; D008565:Membrane Proteins; D000074323:Alemtuzumab